Vivacelle Bio, Inc. — Form D/A

Vivacelle Bio, Inc. of Evanston, IL, a company, filed a Form D amendment with the SEC on 2014-08-08. The offering totals $550K, of which $550K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Paul BurtonDirectorChicago, IL
Paul BurtonExecutive OfficerChicago, IL
Stephen KeithDirectorToronto, A6
Stephen KeithExecutive OfficerToronto, A6
Cuthbert SimpkinsDirectorEvanston, IL
Cuthbert SimpkinsExecutive OfficerEvanston, IL
Ron DamperDirectorEvanston, IL
Diane SimpkinsDirectorEvanston, IL
Diane SimpkinsExecutive OfficerEvanston, IL
Krishna TalluriDirectorEvanston, IL
Krishna TalluriExecutive OfficerEvanston, IL
Harven DeShieldDirectorEvanston, IL
Harven DeShieldExecutive OfficerEvanston, IL
Ron Ormand DamperDirectorChicago, IL
Harven Ormand DeShieldDirectorChicago, IL
Harven Ormand DeShieldExecutive OfficerChicago, IL
Stephen Ormand KeithDirectorChicago, IL
Stephen Ormand KeithExecutive OfficerChicago, IL
Cuthbert Ormand SimpkinsDirectorChicago, IL
Cuthbert Ormand SimpkinsExecutive OfficerChicago, IL
Diane Ormand SimpkinsDirectorChicago, IL
Diane Ormand SimpkinsExecutive OfficerChicago, IL
Edward NicholsExecutive OfficerShreveport, LA

Other filings by this issuer (5)

FiledFormOfferingSold
2019-02-11D/A$3.4M$2.9M
2018-03-13D/A$1.5M$514K
2016-09-09D/A$1.3M$1.3M
2016-08-17D$1.5M$100K
2014-02-13D$1.0M$225K

More